Literature DB >> 9034612

Use of human vessels and human vascular smooth muscle cells in pharmacology.

J C Stoclet1, R Andriantsitohaina, N L'heureux, C Martinez, L Germain, F Auger.   

Abstract

Relatively limited information is available regarding the mechanisms controlling vasomotricity in human vessels. Isolated vessels obtained from patients undergoing surgery were used to characterize the role of endothelial factors and to study coupling mechanisms between receptors, intracellular calcium, and contraction. However, these investigations are limited by the availability of tissues and many uncontrolled factors. Cultured human vascular cells were also used, but these cells rapidly lose at least some of their differentiated characters. Recently, a human blood vessel equivalent was constructed in vitro from cultured cells, using tissue engineering. This technique allowed us to obtain vessel equivalents containing intima, media, and adventitia layers or tubular media layer only. Contraction and rises in intracellular calcium produced by agonists were studied, indicating that such human vessel equivalents may provide valuable models for pharmacological studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9034612     DOI: 10.1007/bf00438149

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  8 in total

Review 1.  The smooth muscle cell in culture.

Authors:  J Chamley-Campbell; G R Campbell; R Ross
Journal:  Physiol Rev       Date:  1979-01       Impact factor: 37.312

2.  Endothelium-independent contractions of human cerebral arteries in response to vasopressin.

Authors:  E Martín de Aguilera; J M Vila; A Irurzun; M C Martínez; M A Martínez Cuesta; S Lluch
Journal:  Stroke       Date:  1990-12       Impact factor: 7.914

3.  O-acylated heparin derivatives with low anticoagulant activity decrease proliferation and increase alpha-smooth muscle actin expression in cultured arterial smooth muscle cells.

Authors:  T Bârzu; A Desmoulière; J M Herbert; M Level; J P Herault; M Petitou; J C Lormeau; G Gabbiani; M Pascal
Journal:  Eur J Pharmacol       Date:  1992-08-25       Impact factor: 4.432

4.  Responses of subcultured rat aortic smooth muscle myocytes to vasoactive agents and KCl-induced depolarization.

Authors:  P Bodin; S Richard; C Travo; P Berta; J C Stoclet; S Papin; P Travo
Journal:  Am J Physiol       Date:  1991-01

5.  In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study.

Authors:  N L'Heureux; L Germain; R Labbé; F A Auger
Journal:  J Vasc Surg       Date:  1993-03       Impact factor: 4.268

6.  Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase.

Authors:  T L Cornwell; T M Lincoln
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

7.  Endothelium-dependent component in the contractile responses of human omental arteries to adrenergic stimulation.

Authors:  M Aldasoro; C Martínez; J M Vila; B Flor; S Lluch
Journal:  Eur J Pharmacol       Date:  1993-11-30       Impact factor: 4.432

8.  Influence of endothelial nitric oxide on neurogenic contraction of human pulmonary arteries.

Authors:  C Martínez; E Cases; J M Vila; M Aldasoro; P Medina; V Marco; S Lluch
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

  8 in total
  3 in total

Review 1.  Tissue engineering of the vascular system: from capillaries to larger blood vessels.

Authors:  L Germain; M Rémy-Zolghadri; F Auger
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

2.  The adventitia: the outs and ins of vascular disease.

Authors:  Patrick J Pagano; David D Gutterman
Journal:  Cardiovasc Res       Date:  2007-07-16       Impact factor: 10.787

Review 3.  The evolution of vascular tissue engineering and current state of the art.

Authors:  Marissa Peck; David Gebhart; Nathalie Dusserre; Todd N McAllister; Nicolas L'Heureux
Journal:  Cells Tissues Organs       Date:  2011-10-13       Impact factor: 2.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.